UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported):	 	June 14, 2017	

Aspen Aerogels, Inc. 
__________________________________________
(Exact name of registrant as specified in its charter)

Delaware	001-36481	04-3559972	
_____________________
(State or other jurisdiction	_____________
(Commission	______________
(I.R.S. Employer	
of incorporation)	File Number)	Identification No.)	
  	 	 	
30 Forbes Road, Building B, Northborough, Massachusetts	 	01532	
_________________________________
(Address of principal executive offices)	 	___________
(Zip Code)	
 	 	 	
Registrant’s telephone number, including area code:	 	(508) 691-1111	
Not Applicable
______________________________________________
Former name or former address, if changed since last report
  
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Top of the Form
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company [ X ]
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [ X ]

Top of the Form
Item 5.07 Submission of Matters to a Vote of Stockholders
(a) On June 14, 2017, Aspen Aerogels, Inc. (the “Company”) held its 2017 annual meeting of stockholders (the “Annual Meeting”). Of the 23,508,417 shares of common stock issued and outstanding and eligible to vote as of the record date of April 20, 2017, a quorum of 20,386,581 shares, or 86.72% of the eligible shares, was present in person or represented by proxy.
(b) The following actions were taken at the Annual Meeting:

1.	 	 The following nominees were reelected to serve on the Company’s Board of Directors as Class III Directors until the 2020 annual meeting of stockholders and until their respective successors are duly elected and qualified, based on the following votes:	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Nominee	 	 	 	Votes For	 	 	 	Votes Withheld	 	 	 	Broker Non-Votes	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Steven R. Mitchell	 	 	 	 	8,883,480	 	 	 	 	 	5,714,426	 	 	 	 	 	5,788,675	 	
Richard F. Reilly	 	 	 	 	12,607,102	 	 	 	 	 	1,990,804	 	 	 	 	 	5,788,675	 	
Donald R. Young	 	 	 	 	12,607,102	 	 	 	 	 	1,990,804	 	 	 	 	 	5,788,675	 	

2.	 	The appointment of KPMG LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017 was ratified, based on the following votes:  	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
Votes For	 	 	 	Votes Against	 	 	 	Abstentions	 	 	 	Broker Non-Votes	
 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	 	
20,251,948	 	 	 	 	125,871	 	 	 	 	 	8,762	 	 	 	 	 	0	 	

Top of the Form
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 14, 2017	 	Aspen Aerogels, Inc.	
 	 	By: /s/ John F. Fairbanks	

 	 	Name: John F. Fairbanks	
                                                                                   	 		
                                                                                   	 	Title: Vice President, Chief Financial
Officer and Treasurer